Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Epilepsy, Date of authorisation: 31/05/2023, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Epilepsy, Date of authorisation: 31/05/2023, Revision: 2, Status: Authorised